Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.


Systemic gene delivery systems are needed for therapeutic application to organs that are inaccessible by percutaneous injection. Currently, the main objective is the development of a stable and non-toxic vector that can encapsulate and deliver foreign genetic material to target cells. To this end, DNA, complexed with cationic lipids i.e. DOTAP/DOPE, was encapsulated into lipid nanocapsules (LNCs) leading to the formation of stable nanocarriers (DNA LNCs) with a size inferior to 130 nm. Amphiphilic and flexible poly (ethylene glycol) (PEG) polymer coatings [PEG lipid derivative (DSPE-mPEG(2000)) or F108 poloxamer] at different concentrations were selected to make DNA LNCs stealthy. Some of these coated lipid nanocapsules were able to inhibit complement activation and were not phagocytized in vitro by macrophagic THP-1 cells whereas uncoated DNA LNCs accumulated in the vacuolar compartment of THP-1 cells. These results correlated with a significant increase of in vivo circulation time in mice especially for DSPE-mPEG(2000) 10 mm and an early half-life time (t(1/2) of distribution) 5-fold greater than for non-coated DNA LNCs (7.1 h vs 1.4 h). Finally, a tumor accumulation assessed by in vivo fluorescence imaging system was evidenced for these coated LNCs as a passive targeting without causing any hepatic damage.

DOI: 10.1016/j.biomaterials.2009.09.044

9 Figures and Tables

Citations per Year

562 Citations

Semantic Scholar estimates that this publication has 562 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Morille2010LongcirculatingDL, title={Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.}, author={Marie Morille and Tristan Montier and Pierre Legras and Nathalie Carmoy and Priscille Brodin and Bruno Pitard and Jean-Pierre Beno{\^i}t and Catherine Passirani}, journal={Biomaterials}, year={2010}, volume={31 2}, pages={321-9} }